Stockreport

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch [Yahoo! Finance]

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF Cormorant Asset Management initiated a new position in Olema Pharmaceuticals (NASDAQ:OLMA) , buying 2,750,000 shares worth $68.75 million in the fourth quarter, accordi [Read more]